Asymmetric pore occupancy in crystal structure of OmpF porin from Salmonella typhi

Journal of Structural Biology

Volumn 178, Issue 3, 2012, Pages 233-244

  Balasubramaniam, D ^a   Arockiasamy, Arulandu ^b   Kumar, P D ^a   Sharma, Amit ^b   Krishnaswamy, S ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Barrel; Asymmetric; Membrane proteins; OmpF; Porins; Refolding

Indexed keywords

OUTER MEMBRANE PROTEIN F;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SALMONELLA TYPHI; STATIC ELECTRICITY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; MOLECULAR SEQUENCE DATA; PORINS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; SALMONELLA TYPHI;

NEGIBACTERIA; SALMONELLA TYPHI;

EID: 84861479553     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2012.04.005     Document Type: Article

References (73)

1. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 2002, 58:1948-1954.
2. Aggarwal A., Kumar S., Jaffe R., Hone D., Gross M., et al. Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med. 1990, 172:1083-1090.
3. Aguilella-Arzo M., Garcia-Celma J.J., Cervera J., Alcaraz A., Aguilella V.M. Electrostatic properties and macroscopic electrodiffusion in OmpF porin and mutants. Bioelectrochemistry 2007, 70:320-327.
4. Alcaraz A., Nestorovich E.M., Lopez M.L., Garcia-Gimenez E., Bezrukov S.M., et al. Diffusion, exclusion, and specific binding in a large channel: a study of OmpF selectivity inversion. Biophys. J. 2009, 96:56-66.
5. Arockiasamy A., Murthy G.S., Rukmini M.R., Sundara Baalaji N., Katpally U.C., et al. Conformational epitope mapping of OmpC, a major cell surface antigen from Salmonella typhi. J. Struct. Biol. 2004, 148:22-33.
6. Basle A., Rummel G., Storici P., Rosenbusch J.P., Schirmer T. Crystal structure of osmoporin OmpC from E. coli at 2.0A. J. Mol. Biol. 2006, 362:933-942.
7. Benz R., Schmid A., Hancock R.E. Ion selectivity of gram-negative bacterial porins. J. Bacteriol. 1985, 162:722-727.
8. Bhandari P., Gowrishankar J. An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer. J. Bacteriol. 1997, 179:4403-4406.
9. Bredin J., Simonet V., Iyer R., Delcour A.H., Pages J.M. Colicins, spermine and cephalosporins: a competitive interaction with the OmpF eyelet. Biochem. J. 2003, 376:245-252.
10. Bredin J., Saint N., Mallea M., De E., Molle G., et al. Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region. Biochem. J. 2002, 363:521-528.
11. CCP4, 1994. The CCP4 suite: programs for protein crystallography. Acta. Crystallogr. D 50, 760-3.
12. Cowan S.W., Schirmer T., Rummel G., Steiert M., Ghosh R., et al. Crystal structures explain functional properties of two E. coli porins. Nature 1992, 358:727-733.
13. Cowan S.W., Garavito R.M., Jansonius J.N., Jenkins J.A., Karlsson R., et al. The structure of OmpF porin in a tetragonal crystal form. Structure 1995, 3:1041-1050.
14. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull. World Health Organ. 2004, 82:346-353.
15. Danelon C., Nestorovich E.M., Winterhalter M., Ceccarelli M., Bezrukov S.M. Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation. Biophys. J. 2006, 90:1617-1627.
16. DeLano, W.L., 2002. The PyMol Molecular Graphic System. DeLano Scientific, San Carlos, CA.
17. Delcour A.H. Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta 2009, 1794:808-816.
18. DeRoeck D., Jodar L., Clemens J. Putting typhoid vaccination on the global health agenda. N. Engl. J. Med. 2007, 357:1069-1071.
19. Dhakshnamoorthy B., Raychaudhury S., Blachowicz L., Roux B. Cation-selective pathway of OmpF porin revealed by anomalous X-ray diffraction. J. Mol. Biol. 2009, 396:293-300.
20. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 2004, 60:2126-2132.
21. Formal S.B., Baron L.S., Kopecko D.J., Washington O., Powell C., et al. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect. Immun. 1981, 34:746-750.
22. Fourel D., Mizushima S., Bernadac A., Pages J.M. Specific regions of Escherichia coli OmpF protein involved in antigenic and colicin receptor sites and in stable trimerization. J. Bacteriol. 1993, 175:2754-2757.
23. Fraillery D., Baud D., Pang S.Y., Schiller J., Bobst M., et al. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin. Vaccine Immunol. 2007, 14:1285-1295.
24. Garcia-Gimenez E., Alcaraz A., Aguilella V.M. Overcharging below the nanoscale: multivalent cations reverse the ion selectivity of a biological channel. Phys. Rev. E 2010, 81:021912.
25. Garcia-Gimenez E., Lopez M.L., Aguilella V.M., Alcaraz A. Linearity, saturation and blocking in a large multiionic channel: divalent cation modulation of the OmpF porin conductance. Biochem. Biophys. Res. Commun. 2011, 404:330-334.
26. Germanier R., Furer E. Isolation and characterization of Gal E mutant Ty21a of Salmonella typhi: a candidate vaccine strain for a live, oral typhoid vaccine. J. Infect. Dis. 1975, 131:553-558.
27. Hajjar E., Kumar A., Ruggerone P., Ceccarelli M. Investigating reaction pathways in rare events simulations of antibiotics diffusion through protein channels. J. Mol. Model. 2010, 16:1701-1708.
28. Hajjar E., Mahendran K.R., Kumar A., Bessonov A., Petrescu M., et al. Bridging timescales and length scales: from macroscopic flux to the molecular mechanism of antibiotic diffusion through porins. Biophys. J. 2010, 98:569-575.
29. Hone D.M., Tacket C.O., Harris A.M., Kay B., Losonsky G., et al. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Invest. 1992, 90:412-420.
30. Im W., Roux B. Ions and counterions in a biological channel: a molecular dynamics simulation of OmpF porin from Escherichia coli in an explicit membrane with 1 M KCl aqueous salt solution. J. Mol. Biol. 2002, 319:1177-1197.
31. Im W., Roux B. Ion permeation and selectivity of OmpF porin: a theoretical study based on molecular dynamics, Brownian dynamics, and continuum electrodiffusion theory. J. Mol. Biol. 2002, 322:851-869.
32. Isibasi A., Ortiz V., Vargas M., Paniagua J., Gonzalez C., et al. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12, d, Vi. Infect. Immun. 1988, 56:2953-2959.
33. Jap B.K., Walian P.J. Biophysics of the structure and function of porins. Q. Rev. Biophys. 1990, 23:367-403.
34. Jeanteur D., Lakey J.H., Pattus F. The bacterial porin superfamily: sequence alignment and structure prediction. Mol. Microbiol. 1991, 5:2153-2164.
35. Jeanteur D., Schirmer T., Fourel D., Simonet V., Rummel G., et al. Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. Proc. Natl. Acad. Sci. USA 1994, 91:10675-10679.
36. Kumar A., Hajjar E., Ruggerone P., Ceccarelli M. Molecular simulations reveal the mechanism and the determinants for ampicillin translocation through OmpF. J. Phys. Chem. B 2010, 114:9608-9616.
37. Kumar P.D., Krishnaswamy S. Overexpression, refolding, and purification of the major immunodominant outer membrane porin OmpC from Salmonella typhi: characterization of refolded OmpC. Protein Expr. Purif. 2005, 40:126-133.
38. Levine M.M., Ferreccio C., Abrego P., Martin O.S., Ortiz E., et al. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 1999, 17(Suppl 2):S22-S27.
39. Lou K.L., Saint N., Prilipov A., Rummel G., Benson S.A., et al. Structural and functional characterization of OmpF porin mutants selected for larger pore size I. Crystallographic analysis. J. Biol. Chem. 1996, 271:20669-20675.
40. Mahendran K.R., Hajjar E., Mach T., Lovelle M., Kumar A., et al. Molecular basis of enrofloxacin translocation through OmpF, an outer membrane channel of Escherichia coli - when binding does not imply translocation. J. Phys. Chem. B 2010, 114:5170-5179.
41. Miedema H., Meter-Arkema A., Wierenga J., Tang J., Eisenberg B., et al. Permeation properties of an engineered bacterial OmpF porin containing the EEEE-locus of Ca2+ channels. Biophys. J. 2004, 87:3137-3147.
42. Moraes T.F., Bains M., Hancock R.E., Strynadka N.C. An arginine ladder in OprP mediates phosphate-specific transfer across the outer membrane. Nat. Struct. Mol. Biol. 2007, 14:85-87.
43. Nakae T. Outer membrane of Salmonella. Isolation of protein complex that produces transmembrane channels. J. Biol. Chem. 1976, 251:2176-2178.
44. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991, 11:281-296.
45. Nikaido H. Transport across the bacterial outer membrane. J. Bioenerg. Biomembr. 1993, 25:581-589.
46. Nikaido H. Porins and specific diffusion channels in bacterial outer membranes. J. Biol. Chem. 1994, 269:3905-3908.
47. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 2003, 67:593-656.
48. Ochiai R.L., Acosta C.J., Agtini M., Bhattacharya S.K., Bhutta Z.A., et al. The use of typhoid vaccines in Asia: the DOMI experience. Clin. Infect. Dis. 2007, 45(Suppl 1):S34-S38.
49. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods in enzymology. Macromol. Crystallogr. A 1997, 276:307-326.
50. Pages J.M., James C.E., Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 2008, 6:893-903.
51. Petrey D., Honig B. GRASP2: visualization, surface properties, and electrostatics of macromolecular structures and sequences. Methods Enzymol. 2003, 374:492-509.
52. Phale P.S., Philippsen A., Widmer C., Phale V.P., Rosenbusch J.P., et al. Role of charged residues at the OmpF porin channel constriction probed by mutagenesis and simulation. Biochemistry 2001, 40:6319-6325.
53. Prince S.M., Feron C., Janssens D., Lobet Y., Achtman M., et al. Expression, refolding and crystallization of the OpcA invasin from Neisseria meningitidis. Acta Crystallogr. D 2001, 57:1164-1166.
54. Puente J.L., Juarez D., Bobadilla M., Arias C.F., Calva E. The Salmonella ompC gene: structure and use as a carrier for heterologous sequences. Gene 1995, 156:1-9.
55. Rosenbusch, J.P., Muller R., 1977. Peeters, H., Massue, J.P. (Eds.), Solubilization of Lipoprotein Complexes, European, Ghent, pp. 56-68.
56. Saint N., Lou K.L., Widmer C., Luckey M., Schirmer T., et al. Structural and functional characterization of OmpF porin mutants selected for larger pore size II. Functional characterization. J. Biol. Chem. 1996, 271:20676-20680.
57. Schirmer T., Phale P.S. Brownian dynamics simulation of ion flow through porin channels. J. Mol. Biol. 1999, 294:1159-1167.
58. Schmid B., Kromer M., Schulz G.E. Expression of porin from Rhodopseudomonas blastica in Escherichia coli inclusion bodies and folding into exact native structure. FEBS Lett. 1996, 381:111-114.
59. Schuermann J.P., Tanner J.J. MRSAD: using anomalous dispersion from S atoms collected at Cu Kalpha wavelength in molecular-replacement structure determination. Acta Crystallogr. D 2003, 59:1731-1736.
60. Secundino I., Lopez-Macias C., Cervantes-Barragan L., Gil-Cruz C., Rios-Sarabia N., et al. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response. Immunology 2006, 117:59-70.
61. Stein N. CHAINSAW: a program for mutating pdb files used as templates in molecular replacement. J. Appl. Cryst. 2008, 41:641-643.
62. Tatavarthy A., Cannons A. Real-time PCR detection of Salmonella species using a novel target: the outer membrane porin F gene (ompF). Lett. Appl. Microbiol. 2010, 50:645-652.
63. Todt J.C., McGroarty E.J. Involvement of histidine-21 in the pH-induced switch in porin channel size. Biochemistry 1992, 31:10479-10482.
64. Toro C.S., Lobos S.R., Calderon I., Rodriguez M., Mora G.C. Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob. Agents Chemother. 1990, 34:1715-1719.
65. Udhayakumar V., Muthukkaruppan V.R. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice. Infect. Immun. 1987, 55:816-821.
66. Van Gelder P., Saint N., van Boxtel R., Rosenbusch J.P., Tommassen J. Pore functioning of outer membrane protein PhoE of Escherichia coli: mutagenesis of the constriction loop L3. Protein Eng. 1997, 10:699-706.
67. Visudtiphole V., Thomas M.B., Chalton D.A., Lakey J.H. Refolding of Escherichia coli outer membrane protein F in detergent creates LPS-free trimers and asymmetric dimers. Biochem. J. 2005, 392:375-381.
68. Vordermeier H.M., Hoffmann P., Gombert F.O., Jung G., Bessler W.G. Synthetic peptide segments from the Escherichia coli porin OmpF constitute leukocyte activators. Infect. Immun. 1990, 58:2719-2724.
69. Vrouenraets M., Miedema H. The ionization state of D37 in E coli porin OmpF and the nature of conductance fluctuations in D37 mutants. Eur. Biophys. J. 2010, 39:1563-1571.
70. Weiss M.S., Kreusch A., Schiltz E., Nestel U., Welte W., et al. The structure of porin from Rhodobacter capsulatus at 1.8A resolution. FEBS Lett. 1991, 280:379-382.
71. Wu J.Y., Newton S., Judd A., Stocker B., Robinson W.S. Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proc. Natl. Acad. Sci USA 1989, 86:4726-4730.
72. Yamashita E., Zhalnina M.V., Zakharov S.D., Sharma O., Cramer W.A. Crystal structures of the OmpF porin: function in a colicin translocon. EMBO J. 2008, 27:2171-2180.
73. Yildiz O., Vinothkumar K.R., Goswami P., Kuhlbrandt W. Structure of the monomeric outer-membrane porin OmpG in the open and closed conformation. EMBO J. 2006, 25:3702-3713.